arrow_back Back to App

Tax Credits for Drug Threat Research by Small Businesses

This act introduces new tax credits for small businesses conducting research on mitigating the effects of drug use, including substances like fentanyl and methamphetamine. The goal is to encourage innovative solutions in combating the drug crisis, potentially enhancing public safety and health.
Key points
Small businesses can receive a 10% tax credit for expenses related to research on preventing and treating the effects of specific drug use.
Research covered includes fentanyl, fentanyl-related substances, methamphetamine, and emerging drug threats.
The aim is to foster innovation that will help address the drug problem in society.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4573
Sponsor: Rep. Neguse, Joe [D-CO-2]
Process start date: 2025-07-21
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Innovate to Save Lives Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4573.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-07-21.

What are the main provisions?

Key points include:

  • Small businesses can receive a 10% tax credit for expenses related to research on preventing and treating the effects of specific drug use.
  • Research covered includes fentanyl, fentanyl-related substances, methamphetamine, and emerging drug threats.
  • The aim is to foster innovation that will help address the drug problem in society.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Neguse, Joe [D-CO-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Ways and Means.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Taxes Health